According to Sun Pharmaceutical 's latest financial reports the company's current EPS (TTM) is $0.43. In 2022 the company made an earnings per share (EPS) of $0.21 a decrease over its 2021 EPS that were of $0.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.43 | 105.72% |
2022 | $0.21 | -42.43% |
2021 | $0.36 | 159.37% |
2020 | $0.14 | -41.54% |
2019 | $0.24 | 13.15% |
2018 | $0.21 | 59.28% |
2017 | $0.13 | -70.24% |
2016 | $0.44 | -13.15% |
2015 | $0.51 | 32.11% |
2014 | $0.39 | 85.16% |
2013 | $0.21 | -11.3% |
2012 | $0.24 |